Record #32931
Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis
Publisher
Original paper date
Jan 4, 2021
Original DOI
Country
Institution
George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, and the Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York 14642 · Chawnshang Chang Sex Hormone Research Center, Tianjin Institute of Urology, Tianjin Medical University, Tianjin 300211, China · Sex Hormone Research Center, China Medical University and Hospital, Taichung 404, Taiwan
Open access
No
Article type
Broad categories
Citation lifecycle
How this paper is being cited
Pre-retraction
89
Same day
1
Post-retraction
23
% post-retraction
20.4%
~4.0 citations/yr after
— citing papers
Who is still citing this work
Loading…